glp 1 receptor antagonists Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A and GLP1 Receptor Agonists History of glucagon-like peptide-1 receptor

GHK-Cu peptides represent a promising option in the aesthetic and regenerative medicine landscape

Yeast screen for modifiers of C9orf72 poly(glycine-arginine) dipeptide repeat toxicity

Those concentrated platelets are then injected directly into the injury site -- a torn tendon, an arthritic joint, a surgical repair site

Microbial metabolites of aromatic amino acids (tryptophan, tyrosine, and phenylalanine)phenolic and indolic compoundsundergo sulfation or glucuronidation in the liver before entering systemic circulation, becoming major sources of protein-bound uremic toxins (104)

Occurrence, outcomes and predictors of portal hypertension in cystic fibrosis: a longitudinal prospective birth cohort study

In Medicine Sciences and Bioengineering: Proceedings of the 2014 International Conference on Medicine Sciences and Bioengineering (ICMSB2014), Kunming, Yunnan, China, August 16-17, 2014 (p